This inventor holds 3 USPTO granted patents. Top assignees: University of Washington, The Cleveland Clinic Foundation, The University of North Carolina at Chapel Hill. Active years: 2010-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 2,173 
2 out of 1,075 
2 out of 1,330 
Years Active: 2010-2020
Title: Innovator Spotlight: Teresa A Brentnall - Pioneering Cancer Detection Methods
Introduction:
Teresa A Brentnall, a talented inventor based in Seattle, WA, has made significant contributions to the field of cancer diagnosis. With a remarkable portfolio of three patents, she has revolutionized the way we detect and assess cancer and precancerous lesions.
Latest Patents:
Teresa's latest patents showcase her dedication to advancing cancer diagnostics. The first patent focuses on "Methods and compositions for cancer diagnosis," introducing innovative reagents and methods for detecting cancer and precancerous lesions in patients. The second patent, "Compositions and methods for detecting cancer," offers methods for identifying individuals at risk of developing cancer and staging the disease. These patents highlight Teresa's commitment to improving cancer detection and patient outcomes.
Career Highlights:
Throughout her career, Teresa has worked with prestigious institutions such as the University of Washington and the University of North Carolina at Chapel Hill. Her expertise and innovative approach have garnered recognition from peers and experts in the field of oncology. Teresa's passion for improving cancer diagnostics has driven her to develop cutting-edge solutions that have the potential to save countless lives.
Collaborations:
Teresa has collaborated with esteemed professionals in the field of cancer research, including Ru Chen and Katherine Lea Pogue-Geile. Together, they have combined their expertise to develop groundbreaking technologies and methodologies for detecting and diagnosing cancer. These collaborations have led to the creation of novel tools and approaches that hold great promise for the future of cancer diagnostics.
Conclusion:
Teresa A Brentnall's groundbreaking work in cancer diagnostics exemplifies her dedication to advancing medical science and improving patient care. Her innovative patents and collaborations underscore her commitment to making a meaningful impact in the fight against cancer. Teresa's contributions are poised to shape the future of cancer detection and treatment, solidifying her legacy as a pioneering inventor in the field of oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile